Chief Executive Officer
Mr. Verrier has spent the last 28 years in medtech, most recently serving as the President of Covidien/Medtronic $1.2B Peripheral Vascular Business. During Brian’s tenure at Covidien the Peripheral Vascular grew from $350M to $1.2B through a series of acquisitions and a focused organic portfolio development strategy. Prior to Covidien Brian spent 14 years in sales and marketing at Medtronic, serving as VP of Sales for the Coronary Business from 2005 – 2010. Over the course of his career, Brian has led the launch of several disruptive medical technologies and substantive M&A transactions. Under his operating leadership, Brian has a reputation of developing aggressive growth strategies, strong operational discipline, building world class teams and exceptional customer focus.